Canaccord Genuity Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
Tweet Send to a Friend
Canaccord Genuity analyst Whitney Ijem reiterated a Hold rating and $93.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
